CIBUS INC (CBUS)
US17166A1016 - Common Stock
Top movers in Wednesday's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Cibus Announces Pricing of Public Offering of Class A Common Stock
Cibus Announces Pricing of Public Offering of Class A Common Stock
SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that...
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing...
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
Initial data from Pod Shatter Reduction field trials show promising results The first gene edited trait to complete field trials in oilseed rape in...
Cibus is Now Oversold (CBUS)
Cibus to Participate in Upcoming August Investor Events
Cibus to Participate in Upcoming August Investor Events
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops plant traits to license...
Cibus is Now Oversold (CBUS)
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cibus (NASDAQ:CBUS) just reported results for the second quarter of 2024.Cibus ...
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q2 2024
CBUS stock results show that Cibus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant...
Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS\
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus’ intellectual property portfolio in its Pod...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are...
Cibus Announces $13.0 Million Registered Direct Offering
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
Cibus to Participate in Upcoming June Investor Events
Cibus to Participate in Upcoming June Investor Events
SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors